|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,038 ILa | -1.48% |
|
+0.17% | +58.32% |
By Brent Kendall and Jared S. Hopkins
WASHINGTON -- The U.S. business of Teva Pharmaceutical Industries Ltd. has been indicted on charges the drugmaker fixed prices on generic drugs, according to a person familiar with the matter.
The Justice Department is expected to announce the charges imminently, the person said.
Write to Brent Kendall at brent.kendall@wsj.com and Jared S. Hopkins at jared.hopkins@wsj.com
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 83.9 USD | +0.64% | +1.49% | - | ||
| 79.56 USD | 0.00% | +2.14% | - | ||
| 16.29 USD | -0.06% | +0.25% | 18.45B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 
